These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23521550)

  • 1. Letter to the Editor: glioma grade.
    Kapoor S
    J Neurosurg; 2013 May; 118(5):1151. PubMed ID: 23521550
    [No Abstract]   [Full Text] [Related]  

  • 2. Response.
    Zhuang Z; Lonser RR
    J Neurosurg; 2013 May; 118(5):1151-2. PubMed ID: 23776936
    [No Abstract]   [Full Text] [Related]  

  • 3. CNTF receptor subunit α as a marker for glioma tumor-initiating cells and tumor grade: laboratory investigation.
    Lu J; Ksendzovsky A; Yang C; Mehta GU; Yong RL; Weil RJ; Park DM; Mushlin HM; Fang X; Balgley BM; Lee DH; Lee CS; Lonser RR; Zhuang Z
    J Neurosurg; 2012 Dec; 117(6):1022-1031. PubMed ID: 23061382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.
    Lee KH; Ahn EJ; Oh SJ; Kim O; Joo YE; Bae JA; Yoon S; Ryu HH; Jung S; Kim KK; Lee JH; Moon KS
    Oncotarget; 2015 Feb; 6(5):3240-53. PubMed ID: 25605251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells.
    Wee B; Pietras A; Ozawa T; Bazzoli E; Podlaha O; Antczak C; Westermark B; Nelander S; Uhrbom L; Forsberg-Nilsson K; Djaballah H; Michor F; Holland EC
    Sci Rep; 2016 Jul; 6():25956. PubMed ID: 27456282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Subpopulations Overexpressing p75NTR Have Tumor-initiating Properties in the C6 Glioma Cell Line.
    Yang WH; Cheng CY; Chen MF; Wang TC
    Anticancer Res; 2018 Sep; 38(9):5183-5192. PubMed ID: 30194166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathological characteristics of glioma stem cell niches.
    He H; Li MW; Niu CS
    J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid binding protein 7 as a marker of glioma stem cells.
    Morihiro Y; Yasumoto Y; Vaidyan LK; Sadahiro H; Uchida T; Inamura A; Sharifi K; Ideguchi M; Nomura S; Tokuda N; Kashiwabara S; Ishii A; Ikeda E; Owada Y; Suzuki M
    Pathol Int; 2013 Nov; 63(11):546-53. PubMed ID: 24274717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells.
    Niu CS; Li DX; Liu YH; Fu XM; Tang SF; Li J
    Oncol Rep; 2011 Sep; 26(3):593-601. PubMed ID: 21573506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of surgical resection of high-grade glioma among the elderly.
    Badhiwala JH; Almenawer SA
    Neuro Oncol; 2015 Jun; 17(6):903-4. PubMed ID: 26023101
    [No Abstract]   [Full Text] [Related]  

  • 11. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
    Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.
    Wu X; Wu F; Xu D; Zhang T
    J Neurooncol; 2016 Apr; 127(2):221-32. PubMed ID: 26757925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection of low-grade gliomas.
    Laws ER
    J Neurosurg; 2001 Nov; 95(5):731-2. PubMed ID: 11702859
    [No Abstract]   [Full Text] [Related]  

  • 15. Expect the unexpected: incidental findings on brain magnetic resonance imaging.
    Lund-Johansen M
    World Neurosurg; 2013 Nov; 80(5):e119-20. PubMed ID: 22858850
    [No Abstract]   [Full Text] [Related]  

  • 16. The rationale to perform early resection in incidental diffuse low-grade glioma: toward a "preventive surgical neurooncology".
    Duffau H
    World Neurosurg; 2013 Nov; 80(5):e115-7. PubMed ID: 22743200
    [No Abstract]   [Full Text] [Related]  

  • 17. Limits of CD133 as a marker of glioma self-renewing cells.
    Clément V; Dutoit V; Marino D; Dietrich PY; Radovanovic I
    Int J Cancer; 2009 Jul; 125(1):244-8. PubMed ID: 19350631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A timeline of cognitive functioning in glioma patients who undergo awake brain tumor surgery: a response to Mahajan et al. and their letter to the editor.
    de Sain AM; van Zandvoort MJE; Mantione MHM; Huenges Wajer IMC; Willems PWA; Robe PA; Ruis C
    Acta Neurochir (Wien); 2023 Sep; 165(9):2501-2502. PubMed ID: 37351674
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.
    Kiviniemi A; Gardberg M; Frantzén J; Parkkola R; Vuorinen V; Pesola M; Minn H
    J Neurooncol; 2015 Sep; 124(2):237-45. PubMed ID: 26033547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans.
    Bleau AM; Howard BM; Taylor LA; Gursel D; Greenfield JP; Lim Tung HY; Holland EC; Boockvar JA
    Neurosurg Focus; 2008; 24(3-4):E28. PubMed ID: 18341405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.